Boehringer-Ingelheim, United States
Boehringer-Ingelheim (Employment)
OP-11E - Comparative Effectiveness of Empagliflozin in Reducing Total Cardiovascular Events in the Empagliflozin Comparative Effectiveness and Safety (EMPRISE) Study
Wednesday, August 25, 20214:30 PM – 6:00 PM US Eastern Time